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2BACKGROUND
Transposons are discrete segments of DNA that have the distinctive ability
to move and replicate within genomes. Transposons were discovered in the
1940’s by Barbara McClintock (who later was awarded with the Nobel Prize
for this discovery) in the maize genome, and have since been found
ubiquitous in essentially all living organisms. The process of element
movement is generally called transposition, and can contribute to insertional
mutagenesis, altered gene expression and recombination. Transposons
make up significant fractions of genomes; for example, about 45% of the
human genome is composed of sequences of a variety of different elements.
Transposons are best viewed as molecular parasites that propagate
themselves using resources of the host cell. The transposition process is
under regulation by both element- and host cell-encoded mechanisms and
factors; these include transcriptional regulation of transposase expression,
regulation of synaptic complex assemby, modulation of both transposon
excision as well as integration by components of the chromatin and various
factors that contribute to the target site selection properties of a given
element. Transposition also has profound effects on the cell’s life by
modulating cellular pathways and gene functions by interacting with host
proteins and by insertional mutagenesis. Despite their parasitic nature, there
is increasing evidence that transposable elements are a powerful force in
gene evolution. Indeed, about 50 human genes are derived from
transposable elements, among them genes that are responsible for
immunoglobulin gene recombination in all vertebrates.
Transposons are natural gene delivery vehicles, and have been
revolutionizing genomic manipulations in diverse model systems.
Transposons have been developed as useful tools for genomic
manipulations, including transgenesis and insertional mutagenesis, in
invertebrate animal systems as well as in plants, but similar technologies
have been impossible in vertebrate systems for a long time, for the simple
reason that the vast majority of DNA transposons are extinct in vertebrate
genomes.
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3AIMS
1 Relics from the past: molecular biology of resurrected transposons
and transposase-derived cellular genes in vertebrates
In this aim we set out to investigate the molecular biology of DNA
transposons in vertebrate genomes. For this purpose we aimed at molecular
reconstruction of active elements, mainly from the Tc1/mariner superfamily.
The main question that we addressed was, first and foremost, can we
reactivate „dead“ elements at all? Can we collect sufficient sequence as well
as phylogenetic information of these transposons that would be required for
their functional reactivation? Second, once we had these elements, we
aimed at using them as experimental systems to address fundemental
questions related to their mechanism of transposition, regulation by both
element- as well as host cell-encoded factors and mechanisms and their
interaction with their cellular environment. Finally, by using the reconstructed
transposons as molecular references for transpositional activities, we set out
to probe the functional properties of domesticated, transposase-derived
cellular genes.
2 DNA transposons as a gene delivery platform for genetic
manupilations in vertebrates
In this aim we set out to establish the resurrected transposons as molecular
tools for genomic manipulations of vertebrate genomes. We specifically
aimed at developing hyperactive transposase mutants as well as
transposon-based vector system of enhanced utility for gene transfer in
vertebrate cells. We further aimed at validating transposon vectors for
delivering shRNA cassettes into cells for stable knockdown of gene
expression. Finally, we aimed at improving the safety profile of transposon-
based gene vectors by employing chromatin insulators to shield
transcriptional activities of transgene cassette and by investigating
technologies for target-selected transposon insertion for the purpose of
human gene therapy.
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4RESULTS
We made the following major discoveries and conclusions:
1. Molecular phylogenetic data were used to construct a synthetic
transposon, Sleeping Beauty (SB), which could be identical or equivalent
to an ancient element that dispersed in fish genomes in part by
horizontal transmission between species. A consensus sequence of a
transposase gene of the salmonid subfamily of elements was engineered
by eliminating the inactivating mutations. SB transposase binds to two
sites (the DRs) within the inverted repeats (IRs) of salmonid transposons
in a substrate-specific manner, and mediates precise, cut-and-paste
transposition in fish as well as in mouse and human cells.
2. We investigated transcriptional activities of SB in order to assess its
potential to alter host gene expression upon integration. The
untranslated regions (UTRs) of the transposon direct convergent,
inwards-directed transcription. Transcription from the 5’-UTR of SB  is
upregulated by the host-encoded factor HMG2L1, and requires a 65-bp
region not present in commonly used SB vectors. The SB transposase
antagonizes the effect of HMG2L1, suggesting that natural transposase
expression is under a negative feedback regulation. SB transposon
vectors lacking the 65-bp region associated with HMG2L1-dependent
upregulation exhibit benign transcriptional activities, at a level up to 100-
times lower than that of the MLV retrovirus long terminal repeat.
3. We established that the DNA-bending, high mobility group protein,
HMGB1 is a host-encoded cofactor of SB transposition. Transposition
was severely reduced in mouse cells deficient in HMGB1. This effect
was rescued by transient overexpression of HMGB1, and was partially
complemented by HMGB2, but not with the HMGA1 protein.
Overexpression of HMGB1 in wild-type mouse cells enhanced
transposition, indicating that HMGB1 can be a limiting factor of
transposition. SB transposase was found to interact with HMGB1 in vivo,
suggesting that the transposase may recruit HMGB1 to transposon DNA.
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5HMGB1 stimulated preferential binding of the transposase to the DR
more distant from the cleavage site, and promoted bending of DNA
fragments containing the transposon IR. We propose that the role of
HMGB1 is to ensure that transposase-transposon complexes are first
formed at the internal DRs, and to subsequently promote juxtaposition of
functional sites in transposon DNA, thereby assisting the formation of
synaptic complexes.
4. We used the SB  element as a tool to probe transposon-host cell
interactions in vertebrates. The Miz-1 transcription factor was identified
as an interactor of the SB transposase in a yeast two-hybrid screen.
Through its association with Miz-1, the SB transposase downregulates
cyclin D1 expression in human cells, as evidenced by differential gene
expression analysis using microarray hybridization. Downregulation of
cyclin D1 results in a prolonged G1 phase of the cell-cycle and retarded
growth of transposase-expressing cells. G1 slowdown is associated with
a decrease of cyclin D1/cdk4-specific phosphorylation of the
retinoblastoma protein. Both cyclin D1 downregulation and the G1
slowdown induced by the transposase require Miz-1. A temporary G1
arrest enhances transposition, suggesting that SB  transposition is
favored in the G1 phase of the cell-cycle, where the nonhomologous end
joining (NHEJ) pathway of DNA repair is preferentially active. Because
NHEJ is required for efficient SB transposition, the transposase-induced
G1 slowdown is probably a selfish act on the transposon’s part to
maximize the chance for a successful transposition event.
5. We have shown that DNA CpG methylation upregulates transposition of
IR/DR elements in the Tc1/mariner superfamily. CpG methylation
provokes the formation of a tight chromatin structure at the transposon
DNA, likely aiding the formation of a catalytically active complex by
facilitating synapsis of sites bound by the transposase.
6. We established that the distribution of experimentally induced SB
insertions in the human genome can be considered fairly random,
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6because most chromosomes can serve as a target; no obvious hotspots
with multiple insertions were found, and no preference for coding versus
non-coding DNA was observed. We further showed that the SB element
displays a certain degree of specificity in target site utilization at the DNA
sequence and structural level. A palindromic AT-repeat consensus
sequence with bendability and a symmetrical pattern of hydrogen
bonding sites in the major groove of the target DNA define preferred
sites for integration.
7. A novel open reading frame-trapping method was used to isolate
uninterrupted transposase coding regions from the genome of the frog
species Rana pipiens. The isolated clones were about 90% identical to a
predicted transposase gene sequence from Xenopus laevis. None of
these native genes was found to be active. Therefore, a consensus
sequence of the transposase gene was derived. This engineered
transposase and the transposon inverted repeats together constitute the
components of a novel transposon system that we named Frog Prince
(FP). FP has only about fifty percent sequence similarity to SB, and
catalyzes efficient cut-and-paste transposition in fish, amphibian and
mammalian cell lines. We demonstrate high-efficiency gene trapping in
human cells using FP transposition. FP is the most efficient DNA-based
transposon from vertebrates described to date, and shows about 70%
higher activity in zebrafish cells than SB. Frog Prince can greatly extend
our possibilities for genetic analyses in vertebrates.
8. Hsmar1, one of the two subfamilies of mariner transposons in humans, is
an ancient element that entered the primate genome lineage ~50 million
years ago. Although Hsmar1 elements are inactive due to mutational
damage, one particular copy of the transposase gene has apparently
been under selection. This transposase coding region is part of the
SETMAR gene, in which a histone methylatransferase SET domain is
fused to an Hsmar1 transposase domain. A phylogenetic approach was
taken to reconstruct the ancestral Hsmar1 transposase gene that we
named Hsmar1-Ra. The Hsmar1-Ra transposase efficiently mobilizes
               dc_67_10
7Hsmar1 transposons by a cut-and-paste mechanism in human cells and
zebrafish embryos. Hsmar1-Ra can also mobilize short inverted-repeat
transposable elements (MITEs) related to Hsmar1 (MiHsmar1), thereby
establishing a functional relationship between an Hsmar1 transposase
source and these MITEs. MiHsmar1 excision is two orders-of-magnitude
more efficient than that of long elements, thus providing an explanation
for their high copy number. We show that the SETMAR protein binds,
and introduces single-strand nicks into Hsmar1 inverted repeat
sequences in vitro. Pathway choice for DNA break repair was found to
be characteristically different in response to transposon cleavage
mediated by Hsmar1-Ra and SETMAR in vivo. Whereas nonhomologous
end-joining plays a dominant role in repairing excision sites generated by
the Hsmar1-Ra transposase, DNA repair following cleavage by SETMAR
predominantly follows a homology-dependent pathway. The novel
transposon system can be a useful tool for genome manipulations in
vertebrates, and for investigations into the transpositional dynamics and
contribution of these elements to primate genome evolution.
9. Ancient, inactive copies of transposable elements of the PIF/Harbinger
superfamily have been described in vertebrates. Based on a predicted
consensus sequence, we reconstructed the functional components of the
Harbinger3_DR transposon in zebrafish, including a transposase and a
second, transposon-encoded protein of unknown function that has a
Myb-like trihelix domain. The reconstructed Harbinger transposon shows
efficient cut-and-paste transposition in human cells, and preferentially
inserts into a 15-bp consensus target sequence. The Myb-like protein is
required for transposition, and physically interacts with the transposase.
The Myb-like protein enables transposition in part by promoting nuclear
import of the transposase, and by binding to the transposon ends. We
investigated the functions of two, transposon-derived human proteins:
HARBI1, a domesticated transposase-derived protein and NAIF1 that
contains a trihelix motif similar to that described in the Myb-like protein.
Physical interaction, subcellular localization and DNA-binding activities of
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8HARBI1 and NAIF1 suggest strong functional homologies between the
Harbinger3_DR system and their related, host-encoded counterparts.
10. The SB transposon is a promising vector for transgenesis in vertebrates,
and is being developed as a novel, nonviral system for gene therapeutic
purposes. A mutagenesis approach was undertaken to improve various
aspects of the transposon, including safety and overall efficiency of gene
transfer in human cells. We constructed a “sandwich” transposon, in
which the DNA to be mobilized is flanked by two complete SB elements
arranged in an inverted orientation. The sandwich element has superior
ability to transpose >10 kb transgenes, thereby extending the cloning
capacity of SB-based vectors. We derived hyperactive versions of the SB
transposase by single-amino-acid substitutions. These mutations act
synergistically, and result in an almost 4-fold enhancement of activity
when compared to the wild-type transposase. We also created a library
of mutant SB transposase genes by using an in vitro evolution paradigm.
One particular mutant, called SB100X , exhibited a ~100-fold
enhancement of transposition as compared to the wild-type transposase,
and showed robust gene transfer efficiencies in mouse embryos as well
as human hematopoietic stem cells. The improved vector system should
prove useful for efficient gene transfer in vertebrates.
11. We have developed a stable RNA interference (RNAi) delivery system
that is based on the FP transposon. This plasmid-based vector system
combines the gene silencing capabilities of H1 polymerase III promoter-
driven short hairpin RNAs (shRNA) with the advantages of stable and
efficient genomic integration of the shRNA cassette mediated by
transposition. We show that the F P-based shRNA expressing system
can efficiently knock down the expression of genes in human cells.
Transposon-mediated genomic integration ensures that the shRNA
expression cassette and a selectable marker gene within the transposon
remain intact and physically linked. We demonstrate that a major
advantage of our vector system over plasmid-based shRNA delivery is
both its enhanced frequency of intact genomic integration as well as
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9higher target suppression in transgenic human cells. Due to its simplicity
and effectiveness, transposon-based RNAi is an emerging tool to
facilitate analysis of gene function through the establishment of stable
loss-of-function cell lines.
12. Transposon-based gene vectors have become indispensable tools in
vertebrate genetics for applications ranging from insertional mutagenesis
and transgenesis in model species to gene therapy in humans. The
transposon toolkit is expanding, but a careful, side-by-side
characterization of the diverse transposon systems has been lacking.
Here we compared the SB, piggyBac and Tol2 transposons with respect
to overall activity, overproduction inhibition (OPI), target site selection
and transgene copy number as well as long-term expression in human
cells. SB was the most efficient system under conditions where the
availability of the transposon DNA is limiting the transposition reaction
including hard-to-transfect hematopoietic stem/progenitor cells, and the
most sensitive to OPI, underpinning the need for careful optimization of
the transposon components. SB  and piggyBac were about equally
active, and both more efficient than Tol2, under nonrestrictive conditions.
All three systems provided long-term transgene expression in human
cells with minimal signs of silencing. SB, Tol2 and piggyBac constitute
complementary research tools for gene transfer in mammalian cells with
important implications for fundamental and translational research.
13. Incorporation of chicken beta-globin HS4 insulator sequences in SB-
based vectors reduces transactivation of model promoters by
transposon-borne enhancers, and thus may lower the risk of
transcriptional activation of host genes situated close to a transposon
insertion site.
14. Random chromosomal transposition is clearly undesired for human gene
therapeutic applications due to potential genotoxic effects associated
with transposon integration. We demonstrated targeted chromosomal
insertion of the SB  transposon in human cells. We established a
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successful strategy based on targeting proteins that can bind both
transposon and target DNA to direct SB element transposition into the
vicinity of a specific DNA sequence in the human genome. Furthermore,
transposon targeting based on protein-protein interactions between the
SB transposase and a targeting fusion containing the N-terminal protein
interaction domain of S B  is a successful strategy to direct SB
integrations into a given locus in the human genome. This approach was
found to enable a ~107-fold enrichment of transgene insertion at a
desired locus. Our results provide proof-of-principle for directing
chromosomal insertion of an otherwise randomly integrating genetic
element into preselected sites. Targeted transposition could be a
powerful technology for safe transgene integration in human
applications.
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